FOXP3 and autoimmune disease: By establishing Treg cells as a critical contributor to the therapeutic effects of systemic IGF-1 delivery in autoimmune disease, our report builds on previous studies documenting decreased Treg numbers and FoxP3 expression in the inflamed pancreas of autoimmune mice (Feuerer et al, 2009; Bluestone et al, 2010).